Prestige Consumer Healthcare Inc.

XNYSHealth care

Last traded price · USD

$53.28

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $53.28
Volume: —
Day's high: —
Day's low: —

In brief

Prestige Consumer Healthcare Inc. is a health care company listed on the New York Stock Exchange, valued at about $2.52B.
Its shares closed at $53.28 on 4 Nov 2026, down 12.0% over the past year.
From India you can buy PBH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Prestige Consumer Healthcare Inc. (PBH) shares from India?

Yes. Indian residents can invest in the US stock market under the Reserve Bank of India's Liberalised Remittance Scheme (LRS), which lets a resident individual remit up to USD 250,000 per financial year, across all permitted purposes combined. US-listed stocks and ETFs are a permitted investment under the LRS. You are solely responsible for ensuring your remittances comply with the LRS annual limit, the applicable Tax Collected at Source (TCS) rules, and all reporting requirements, including Schedule FA in your income-tax return.

Do I need the price of a whole PBH share to invest?

Yes. You can buy fractional shares, which lets you invest a fixed rupee/dollar amount even in high-priced stocks. For example, if one share trades at USD 1,000 and you invest USD 100, you receive 0.1 of a share.

How much can I invest in US stocks in a year?

Under the LRS, an Indian resident can remit up to USD 250,000 per financial year (April to March) across all permitted purposes combined, from their own funds. This is a per-individual limit set by the RBI.

Can I trade PBH options or futures?

No. Under RBI / FEMA rules, the LRS does not permit margin trading or speculative instruments such as futures, options, or other derivatives. Your US account is a cash account, not a derivatives and margin account.

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +14.7% (SPY −1.6%, XLV +13.5%). 3 months: +0.6% (SPY −0.4%, XLV +15.5%). 1 year: −12.0% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PBH, SPY and XLV · as of 4 Nov 2026
Rose 7.5% on 4 Nov 2026
The 4 Nov 2026 gain of 7.5% was 4.9× its average daily move of 1.6% over the past year, and its largest one-day gain since 6 Feb 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
7.3 days to cover short interest
4.0M shares were sold short at the 15 Oct 2026 settlement, 8.4% of the 47.4M shares outstanding; covering them would take 7.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $53.28 was 9.9% above its 50-day average ($48.48) and 1.1% below its 200-day average ($53.87). It has closed below the 200-day for 170 sessions, since 5 Mar 2026. The 50-day average crossed below the 200-day on 31 Jul 2025, 318 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
37% of the way up its 52-week range
Closed at $53.28 on 4 Nov 2026: 25.0% below the 52-week high of $71.07 (24 Feb 2026) and 25.0% above the low of $42.62 (14 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+14.7%

6 months−1.9%

1 year−12.0%

5 years−13.6%

Newswire

About

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.

Website

Notable moves

May 14, 2026
−11.35%
August 7, 2025
−10.05%
February 6, 2025
+14.78%

Newswire

About

Website

Notable moves

May 14, 2026
−11.35%
August 7, 2025
−10.05%
February 6, 2025
+14.78%

Prestige Consumer Healthcare Inc.

XNYSHealth care

Last traded price · USD

$53.28

+0.00%Delayed · Pre-market

Delayed 15 minutes · Source: ViewTrade · 5 Nov 2026, 14:39 IST · A quote does not mean the product is available to trade on your account.

Day's open: —
Previous close: $53.28
Volume: —
Day's high: —
Day's low: —

In brief

Prestige Consumer Healthcare Inc. is a health care company listed on the New York Stock Exchange, valued at about $2.52B.
Its shares closed at $53.28 on 4 Nov 2026, down 12.0% over the past year.
From India you can buy PBH in US dollars under the RBI's Liberalised Remittance Scheme, including a fraction of one share. See what it costs

Questions investors ask

Can I buy Prestige Consumer Healthcare Inc. (PBH) shares from India?

Do I need the price of a whole PBH share to invest?

How much can I invest in US stocks in a year?

Can I trade PBH options or futures?

Insights

Quotes run fifteen minutes behind.

Behind SPY and its sector fund XLV over 1 year
1 month: +14.7% (SPY −1.6%, XLV +13.5%). 3 months: +0.6% (SPY −0.4%, XLV +15.5%). 1 year: −12.0% (SPY +13.6%, XLV +30.7%). Price change to the 4 Nov 2026 close; dividends excluded.
Daily closes, split-adjusted: PBH, SPY and XLV · as of 4 Nov 2026
Rose 7.5% on 4 Nov 2026
The 4 Nov 2026 gain of 7.5% was 4.9× its average daily move of 1.6% over the past year, and its largest one-day gain since 6 Feb 2025.
Daily closes, split-adjusted · as of 4 Nov 2026
7.3 days to cover short interest
4.0M shares were sold short at the 15 Oct 2026 settlement, 8.4% of the 47.4M shares outstanding; covering them would take 7.3 days of average volume. Short interest is reported twice a month, on a lag.
Exchange short-interest filing · as of 15 Oct 2026
Above its 50-day average, below its 200-day
The 4 Nov 2026 close of $53.28 was 9.9% above its 50-day average ($48.48) and 1.1% below its 200-day average ($53.87). It has closed below the 200-day for 170 sessions, since 5 Mar 2026. The 50-day average crossed below the 200-day on 31 Jul 2025, 318 sessions ago.
Daily closes, split-adjusted; 50- and 200-session simple averages · as of 4 Nov 2026
37% of the way up its 52-week range
Closed at $53.28 on 4 Nov 2026: 25.0% below the 52-week high of $71.07 (24 Feb 2026) and 25.0% above the low of $42.62 (14 May 2026).
Daily price bars, split-adjusted · as of 4 Nov 2026

Returns

Price return, split-adjusted

At the 4 Nov 2026 close

1 month+14.7%

6 months−1.9%

1 year−12.0%

5 years−13.6%

Newswire

About

Website

Notable moves

May 14, 2026
−11.35%
August 7, 2025
−10.05%
February 6, 2025
+14.78%

Newswire

About

Website

Notable moves

May 14, 2026
−11.35%
August 7, 2025
−10.05%
February 6, 2025
+14.78%

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. in brief

Behind SPY and its sector fund XLV over 1 year

Rose 7.5% on 4 Nov 2026

7.3 days to cover short interest

Above its 50-day average, below its 200-day

37% of the way up its 52-week range

Prestige Consumer Healthcare Inc.

Prestige Consumer Healthcare Inc. in brief

Behind SPY and its sector fund XLV over 1 year

Rose 7.5% on 4 Nov 2026

7.3 days to cover short interest

Above its 50-day average, below its 200-day

37% of the way up its 52-week range